Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use